Your browser doesn't support javascript.
Obesity and COVID-19: What are the Consequences?
Steenblock, Charlotte; Hassanein, Mohamed; Khan, Emran G; Yaman, Mohamad; Kamel, Margrit; Barbir, Mahmoud; Lorke, Dietrich E; Everett, Dean; Bejtullah, Saqipi; Lohmann, Tobias; Lindner, Uwe; Tahirukaj, Ermal; Jirjees, Feras Jassim; Soliman, Sameh S M; Quitter, Friederike; Bornstein, Stefan R.
  • Steenblock C; Department of Medicine III, Universitätsklinikum Carl Gustav Carus, Dresden, Germany.
  • Hassanein M; Department of Diabetes and Endocrinology, Dubai Hospital, Dubai, United Arab Emirates.
  • Khan EG; Endocrinology and Diabetology, King's College Hospital London, Dubai, United Arab Emirates.
  • Yaman M; Building 6, Nesmah Technology, Dubai, United Arab Emirates.
  • Kamel M; Center for Regenerative Therapies Dresden, Technische Universitat Dresden, Dresden, Germany.
  • Barbir M; Department of Cardiology, Harefield Hospital, Harefield, United Kingdom of Great Britain and Northern Ireland.
  • Lorke DE; Department of Anatomy and Cellular Biology, Khalifa University, Abu Dhabi, United Arab Emirates.
  • Everett D; Department of Pathology and Infectious Diseases, Khalifa University, Abu Dhabi, United Arab Emirates.
  • Bejtullah S; Research Unit, College Heimerer, Prishtina, Republic of Kosovo.
  • Lohmann T; MK5, Städtisches Klinikum Dresden, Dresden, Germany.
  • Lindner U; Internal Medicine II, Klinikum Chemnitz, Chemnitz, Germany.
  • Tahirukaj E; Department of Medicine III, Universitätsklinikum Carl Gustav Carus, Dresden, Germany.
  • Jirjees FJ; College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates.
  • Soliman SSM; College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates.
  • Quitter F; Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Carl Gustav Carus, Dresden, Germany.
  • Bornstein SR; Department of Medicine III, Universitätsklinikum Carl Gustav Carus, Dresden, Germany.
Horm Metab Res ; 54(8): 496-502, 2022 Aug.
Article in English | MEDLINE | ID: covidwho-1900713
ABSTRACT
Obesity is an increasing health problem all over the world. In combination with the current COVID-19 pandemic, this has turned into a massive challenge as individuals with overweight and obesity at all ages show a significant increase in their risk of getting severe COVID-19. Around 20% of all patients that were hospitalized for COVID-19 suffered from obesity alone, whereas obesity in combination with other metabolic comorbidities, such as type 2 diabetes and hypertension, account for up to 60% of all hospitalizations in relation to COVID-19. Therefore, it is of immense importance to put the spotlight on the high incidence of obesity present already in childhood both by changing the individual minds and by encouraging politicians and the whole society to commence preventive interventions for achieving a better nutrition for all social classes all over the world. In the current review, we aim to explain the different pathways and mechanisms that are responsible for the increased risk of severe COVID-19 in people with overweight and obesity. Furthermore, we discuss how the pandemic has led to weight gains in many people during lockdown. At the end, we discuss the importance of preventing such an interface between a non-communicable disease like obesity and a communicable disease like COVID-19 in the future.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Horm Metab Res Year: 2022 Document Type: Article Affiliation country: A-1878-9757

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Horm Metab Res Year: 2022 Document Type: Article Affiliation country: A-1878-9757